BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19745696)

  • 1. Prostate cancer modality time trend analyses from 1973 to 2004: a Surveillance, Epidemiology, and End Results registry analysis.
    Jani AB; Johnstone PA; Liauw SL; Master VA; Rossi PJ
    Am J Clin Oncol; 2010 Apr; 33(2):168-72. PubMed ID: 19745696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A surveillance, epidemiology, and end results registry analysis of prostate cancer modality time trends by age.
    Terakedis BE; Rossi PJ; Liauw SL; Johnstone PA; Jani AB
    Am J Clin Oncol; 2010 Dec; 33(6):619-23. PubMed ID: 20051808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
    Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A surveillance, epidemiology, and end results population study.
    Lee CM; Szabo A; Shrieve DC; Macdonald OK; Tward JD; Skidmore TB; Gaffney DK
    Cancer; 2007 Nov; 110(9):2092-100. PubMed ID: 17849468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
    Jani AB; Johnstone PA; Liauw SL; Master VA; Brawley OW
    Am J Clin Oncol; 2008 Aug; 31(4):375-8. PubMed ID: 18845997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.
    Zelefsky MJ; Moughan J; Owen J; Zietman AL; Roach M; Hanks GE
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1053-61. PubMed ID: 15234039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
    Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
    Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate-risk localized prostate cancer in the PSA era: radiotherapeutic alternatives.
    Gondi V; Deutsch I; Mansukhani M; O'Toole KM; Shah JN; Schiff PB; Katz AE; Benson MC; Goluboff ET; Ennis RD
    Urology; 2007 Mar; 69(3):541-6. PubMed ID: 17382161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S.
    Mettlin CJ; Murphy GP; McDonald CJ; Menck HR
    Cancer; 1999 Nov; 86(9):1877-82. PubMed ID: 10547563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.
    Wong WW; Schild SE; Vora SA; Halyard MY
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):24-9. PubMed ID: 15337536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis.
    Hoffman KE; Hong TS; Zietman AL; Russell AH
    Cancer; 2008 Feb; 112(4):943-9. PubMed ID: 18098220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy.
    Vargas CE; Demanes J; Boike TP; Barnaba MC; Skoolisariyaporn P; Schour L; Gustafson GS; Gonzalez J; Martinez AA
    Am J Clin Oncol; 2006 Oct; 29(5):451-7. PubMed ID: 17023778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of survival benefit of post-operative radiation therapy in prostate cancer patients with positive lymph nodes.
    Johnstone PA; Assikis V; Goodman M; Ward KC; Riffenburgh RH; Master V
    Prostate Cancer Prostatic Dis; 2007; 10(2):185-8. PubMed ID: 17211440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results.
    Demanes DJ; Rodriguez RR; Schour L; Brandt D; Altieri G
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1306-16. PubMed ID: 15817332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.